Journal Article Summary
The article examines the availability of results from completed phase III clinical trials focused on diabetic nephropathy, a serious complication of diabetes that can lead to end-stage renal disease. This topic is significant because diabetic nephropathy affects a large number of individuals with diabetes, and understanding the effectiveness of various treatments is crucial for improving patient outcomes. The authors highlight the importance of timely publication of clinical trial results to inform treatment decisions and ensure ethical obligations to study participants are met.
In their analysis, the researchers identified 34 completed phase III clinical trials registered on ClinicalTrials.gov as of June 2017. They found that only 22 of these trials (about 69%) were published, leaving 12 unpublished, which included data on over 1,000 patients and various interventions. The published studies primarily tested medications such as angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers, but most showed only weak effects on kidney health, with minimal improvements in renal outcomes like proteinuria and glomerular filtration rate.
The study has limitations, including its reliance on ClinicalTrials.gov and the potential for publication bias, as trials with positive results are more likely to be published. Patients should be aware that many clinical trials may not report their findings, which can hinder the understanding of treatment effectiveness. It is advisable for readers to discuss these findings and any concerns about diabetic nephropathy and its treatments with their healthcare providers to ensure they receive the most informed care possible.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Modafferi Sergio, Ries Markus, Calabrese Vittorio, Schmitt Claus. P., Nawroth Peter, Kopf Stefan, Peters Verena. Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis. Diabetes Therapy 2019. DOI: 10.1007/s13300-018-0551-9. PMID: 30617943. PMCID: PMC6349284.
Featured Pill Pals Product
Indapamide 1.25 mg Tablets --- Generic For Lozol --- ANI Pharma
Indapamide 1.25 mg Tablets — Generic For Lozol — ANI Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
